Key points
- Stimulant labels state that the medication may produce tolerance, defined as a reduced response after repeated use.
- A 2022 review found few studies of long-term tolerance: one reported 24.7% of patients developing tolerance within days to weeks, another 2.7% over ten years.
- In the Vyvanse adult maintenance study, benefit persisted after six months of treatment: 9% treatment failure on continued medication against 75% on placebo.
- In 2014 the FDA said two generic versions of Concerta might not produce the same therapeutic effect as the brand and changed their equivalence rating.
- The Adderall XR label says acidifying agents lower amphetamine levels and efficacy, and proton pump inhibitors shorten the time to peak levels.
"It's not working like it used to" is one of the most common things adults tell ADHD prescribers. Sometimes that is tolerance, a real reduction in the body's response to a drug. Just as often it is something else: the medication wearing off at a predictable time each day, a change in the product the pharmacy dispensed, another medication, poor sleep, or a harder job. This page separates those possibilities so you can bring useful information to your prescriber. It contains no dosing information, and it is not a reason to change how you take your medication.
What the FDA label means by tolerance
Stimulant labels state that the medication may produce tolerance, and define it as a physiological state in which repeated use leads to a reduced response, so that a higher dose is needed to get the effect once produced by a lower one. The labels list tolerance alongside physical dependence and separately from addiction. Needing a change in your treatment plan is not, by itself, a sign of addiction. The difference is explained in ADHD medication misuse and addiction risk.
Three kinds of "it stopped working"
1. Daily wearing off
Every ADHD medication has a duration of effect. Short-acting forms cover part of a day, and extended-release forms are designed to cover more. In a Vyvanse study set up to simulate a workday, adults were tested from 2 to 14 hours after taking it, and attention was better than on placebo at every time point measured. In children taking Concerta, improvements in classroom studies were maintained through 12 hours after dosing. Your own experience may differ, and many adults have days that run longer than any study. How release systems work is covered in extended-release ADHD medications explained.
Wearing off is predictable: it happens around the same time each day. That pattern is the clue that separates it from tolerance.
2. Tolerance within a single day
A 1999 laboratory classroom study in children found evidence of acute tolerance to methylphenidate. When blood levels were held flat through the day, the effect declined by the afternoon, while a profile that rose across the day kept working. The authors said this should be considered when designing dosing regimens. The Concerta label describes this kind of shape: an initial peak at about one hour, then gradually rising levels over the next 5 to 9 hours before a gradual decline.
3. Tolerance over months or years
Long-term tolerance is less well studied than most people expect. A 2022 literature review found relatively few studies. One clinical study it cited reported that 24.7% of patients developed tolerance within days to weeks, while another reported 2.7% over ten years. The review noted that long-term follow-up studies suggest the response may lessen over longer periods in many patients, and it called for more research and clearer guidance for clinicians.
Not everyone loses benefit over time. In the Vyvanse adult maintenance study, adults who had taken lisdexamfetamine for at least six months and were still responding were randomly assigned to continue or switch to placebo. Treatment failure occurred in 9% of those who continued and 75% of those switched to placebo over six weeks, according to the label.
Other explanations to rule out
| What you notice | Possible explanation | What to bring to the prescriber |
|---|---|---|
| Effect fades at about the same time every day | Normal duration of the product, or a schedule longer than it covers | The time you take it, when you feel it start and when it fades, and the hours you need covered |
| Change started right after a refill looked different | A different manufacturer or formulation was dispensed | The pharmacy label and the manufacturer name, or a photo of the tablets |
| Change started after a new prescription or supplement | A drug interaction | A full list of everything you take, including over-the-counter products |
| Gradual decline over months | Possible tolerance, or growing demands at work or home | Symptom ratings over time, and what changed in your life |
| Short sleep, high stress, low mood or more anxiety | Another condition or circumstance masking the benefit | Sleep times, mood notes and anything new in your health |
Generic switches
Generic versions approved as therapeutically equivalent are expected to work the same way. There has been at least one exception in this class. In 2014 the FDA said it had concerns that two generic versions of Concerta, made by Mallinckrodt and Kudco, might not produce the same therapeutic effect as the brand. It changed their equivalence rating, and in 2016 it proposed withdrawing their approval. During shortages, pharmacies may dispense whichever manufacturer they can get. As of October 2026, the FDA lists methylphenidate extended-release, lisdexamfetamine and mixed amphetamine salts immediate-release in shortage. See brand vs generic Concerta and what to do in a shortage.
Other medications and stomach acid
The Adderall XR label lists several interactions that can change how amphetamine works. Acidifying agents lower amphetamine blood levels and efficacy, alkalinizing agents raise them, and proton pump inhibitors (a type of acid reducer) shorten the time to peak levels. The label tells prescribers to monitor for changes in clinical effect. More examples are in ADHD medication drug interactions.
Sleep, stress and other conditions
NICE guidance lists the effect of medication on existing or new mental health and physical conditions, and how well treatment works throughout the day, among the things to cover in a medication review. Sleep loss and caffeine can blur the picture too. See ADHD medication and sleep and ADHD medication and caffeine.
Why not just take more?
Taking more than prescribed, or taking it more often, is what stimulant labels define as misuse, even when the goal is to get through work. It also creates practical problems. In New York, Schedule II prescriptions cannot be refilled, so running short leaves you without medication until a new prescription can be filled. The FDA tells prescribers to watch for renewal requests that come sooner than the prescribed amount would explain. Raising the problem early keeps the conversation about treatment, not about running out.
What a prescriber may consider
The 2022 tolerance review listed strategies used in practice: switching to a different stimulant, planned breaks from medication, and clinical reassessment. Other possibilities include changing the timing or formulation, or reviewing other conditions and medications. Which, if any, applies to you is a decision for you and your prescriber. Breaks from medication are discussed in stopping ADHD medication.
Questions to bring to your next visit
- Is what I describe more likely wearing off, tolerance or something else?
- How long should this product last, and does that match my day?
- Did the pharmacy dispense the same manufacturer as before?
- Could any of my other medications or supplements affect it?
- Would a symptom rating scale help us compare now with when it was working?
- What would you consider changing, and what are the trade-offs?
When to call sooner, and when to get emergency care
- Call the prescriber if you feel an urge to take more than prescribed, if you are running out early, or if mood, anxiety or sleep worsen.
- Call 911 for chest pain, fainting or a racing, irregular heartbeat. Stimulant labels tell patients to contact a health care provider immediately for exertional chest pain or unexplained fainting.
- Call or text 988 for thoughts of harming yourself.
Dr. Shershow, a psychiatrist licensed in New York and New Jersey who focuses on adult ADHD, provides medication management with ongoing follow-up. See adult ADHD treatment or how often ADHD follow-up visits happen.
Questions
Do you build up a tolerance to ADHD medication?
Stimulant labels say tolerance may occur. Research on long-term tolerance is limited, and estimates vary widely, from a few percent over ten years to about a quarter of patients over days to weeks in different studies. Many adults keep benefiting, as the Vyvanse adult maintenance study showed.
Why does my medication wear off in the afternoon?
Every product has a limited duration, and a long workday may outlast it. Note the time you take it, when you feel it start and when it fades, and share that with your prescriber, who can consider timing or formulation.
My refill looks different and works worse. Is that possible?
Generics rated therapeutically equivalent are expected to work the same, but the FDA did raise concerns in 2014 about two generic Concerta products. Tell your prescriber and pharmacist, and bring the manufacturer name from the label.
Can I take an extra dose when it wears off early?
Not without your prescriber's instruction. Stimulant labels define taking more than prescribed as misuse, and in New York you cannot refill a Schedule II prescription early, so you could run out. Ask the prescriber about the problem instead.
Do medication breaks prevent tolerance?
A 2022 review listed planned breaks among strategies used for tolerance, but evidence is limited. Any break should be planned with the prescriber, because some medications should not be stopped suddenly.
Sources
- DailyMed (National Library of Medicine): Adderall XR prescribing information and Medication Guide, label effective April 30, 2026
- DailyMed (National Library of Medicine): Vyvanse prescribing information and Medication Guide, label effective April 30, 2026
- DailyMed (National Library of Medicine): Concerta prescribing information and Medication Guide, label effective April 20, 2026
- Handelman and Sumiya, Brain Sciences 2022;12(8):959: tolerance to stimulant medication for ADHD, literature review and case report
- Swanson et al., Clinical Pharmacology and Therapeutics 1999;66(3):295-305: acute tolerance to methylphenidate in children with ADHD (PubMed)
- US Food and Drug Administration: Methylphenidate hydrochloride extended-release tablets (generic Concerta) made by Mallinckrodt and Kudco
- US Food and Drug Administration: Drug Shortages database (checked October 2026)
- National Institute for Health and Care Excellence (UK): ADHD diagnosis and management, guideline NG87, recommendations (updated 2019)
- New York Codes, Rules and Regulations: 10 NYCRR 80.67, Schedule II and certain other substances (no refills)
- US Food and Drug Administration: FDA updating warnings to improve safe use of prescription stimulants (May 11, 2023)
